Table of Content

Open Access Review

Malignancy in the Lung Transplant Population

Received: 16 July 2017;  Published: 12 September 2017;  doi: 10.21926/obm.transplant.1703004


The risk for developing a variety of malignancies is significantly elevated in the setting of lung transplantation. Malignancy remains among the three major causes of death in post-transplant recipients, and the relatively high risk of cancer development as well as metastatic aggression pose special [...]

143 1369

Open Access Review

IVIG Replacement for Hypogammaglobulinemia in Lung Transplant Patients

Received: 10 March 2017;  Published: 22 June 2017;  doi: 10.21926/obm.transplant.1701003


After lung transplant, infection is a leading contributor to morbidity and mortality, and hypogammaglobulinemia (HGG) may be an important risk factor for many of these infections.  Some reports suggest that HGG not only increases the risk of various infections, but also worsens survival.  The incide [...]

201 1978

Open Access Review

Anti-HLA Antibodies in Lung Transplantation

Received: 22 February 2019;  Published: 11 April 2017;  doi: 10.21926/obm.transplant.1701002


(1) Background: Lung transplantation is an increasingly utilized treatment for end-stage lung disease. Scarcity of organ donors limiting transplantation underscores the importance of optimal histocompatibility testing approaches to facilitate organ allocation and avoid immunologic rejection. Signifi [...]

186 1639

Open Access Editorial

OBM Transplantation—A New Hub in the Network of Transplantation Science

Received: 07 April 2017;  Published: 11 April 2017;  doi: 10.21926/obm.transplant.1701001

176 2224